Device registrations
20 device registrations appeared in United States during Week 18, 2026. Registration activity can expose product category momentum, manufacturer movement, and database changes that affect market intelligence.
Signals from 2026-04-27 to 2026-05-03, covering safety alerts, regulatory changes, device registrations, market movement, and source activity for United States.
United States generated 42 qualifying medical device signals during Week 18, 2026. Device registrations led the week with 20 signals, while EUDAMED EU Device Database was the most active source. Mizuho Orthopedic Systems, Inc. registered the PKIT, ULTRA SHOULDER, MULTIFLEX PAD as Class I devices in EUDAMED. Mizuho Orthopedic Systems, Inc. registered the PKIT, ULTRA SHOULDER, and REHAB SLING as Class I devices.
20 device registrations appeared in United States during Week 18, 2026. Registration activity can expose product category momentum, manufacturer movement, and database changes that affect market intelligence.
6 commercial launches appeared in United States during Week 18, 2026. Competitor-linked activity is most useful when paired with product codes, indication context, and adjacent safety signals.
3 market trends appeared in United States during Week 18, 2026. Market signals help connect regulatory monitoring with launch planning, reimbursement, and commercial strategy.
3 safety recalls appeared in United States during Week 18, 2026. Safety concentration usually matters to quality, vigilance, and post-market surveillance teams because it can reveal emerging field risks.
These source-linked items support the weekly analysis above. They are included for verification and follow-up, not as a raw feed export.
Mizuho Orthopedic Systems, Inc. registered the PKIT, ULTRA SHOULDER, MULTIFLEX PAD as Class I devices in EUDAMED.
SourceMizuho Orthopedic Systems, Inc. registered the PKIT, ULTRA SHOULDER, and REHAB SLING as Class I devices.
SourceOrthopedic surgery is transforming through interconnected digital ecosystems, enhancing precision and patient care.
SourcePixee Medical's Knee+ NexSight receives FDA 510(k) clearance for augmented reality in total knee arthroplasty.
SourceThe Axcess Percutaneous Catheter by Argon Medical Devices is classified as Class IIa and registered in EUDAMED.
SourceThe review highlights the supply chain resilience challenges in the pharma and medical devices sectors.
SourceThe FDA has released draft guidance on best practices for responding to Form 483 after inspections.
SourceThe FDA reports nearly 30 serious injuries linked to recalled Omnipod 5 insulin delivery pods.
SourceAI integration in medical devices requires understanding regulatory status and managing training data as a device component.
SourceA new AI-driven robotic system can autonomously perform cardiac ultrasounds, enhancing access in underserved areas.
SourceDeviceTalks Boston 2026 will feature keynotes and panels from medical device OEMs on May 27-28.
SourceNearly 60% of healthcare professionals are concerned about cybersecurity risks to medical devices, per a RunSafe survey.
SourceMizuho Orthopedic Systems, Inc. registered the PKIT, ULTRA SHOULDER, MULTIFLEX PAD as Class I devices in EUDAMED.
SourceMizuho Orthopedic Systems, Inc. registered the PKIT, ULTRA SHOULDER, and REHAB SLING as Class I devices.
SourcePixee Medical's Knee+ NexSight receives FDA 510(k) clearance for augmented reality in total knee arthroplasty.
SourceThe Axcess Percutaneous Catheter by Argon Medical Devices is classified as Class IIa and registered in EUDAMED.
Source3M's FUTURO™ Plantar Fasciitis Night Support is a Class I medical device registered in EUDAMED.
SourceCell Marque Corporation's SF-1 Rabbit Monoclonal Antibody is classified as Class C in EUDAMED.
SourceArgon Medical Devices, Inc. registered the One Piece/Tuohy-Borst device classified as Class IIa.
SourceArgon Medical Devices, Inc. registered a Class IIa One-Piece Catheter with UDI-DI 20886333213690.
SourceA new AI-driven robotic system can autonomously perform cardiac ultrasounds, enhancing access in underserved areas.
SourceAidoc raised $150M to enhance its AI platform across 2,000 hospitals, aiming for comprehensive diagnostic solutions.
SourceDr. Eric Rosenberg performed the first cataract surgery using Apple Vision Pro and ScopeXR, enhancing surgical precision.
SourceIlluminant's Skylight projects real-time anatomical images on patients during spine surgery to enhance precision.
SourceAxoft raised $55M for iBCIs and Fleuron material trials, enhancing global clinical and regulatory efforts.
SourceA portable TB diagnostic tool matches traditional tests' accuracy and meets WHO near-point-of-care standards.
SourceOrthopedic surgery is transforming through interconnected digital ecosystems, enhancing precision and patient care.
SourceNearly 60% of healthcare professionals are concerned about cybersecurity risks to medical devices, per a RunSafe survey.
SourceEmory University is enhancing surgical training with da Vinci tools, improving efficiency and skill assessment.
SourceThe FDA reports nearly 30 serious injuries linked to recalled Omnipod 5 insulin delivery pods.
SourceMedline recalls specific Convenience Kits with unapproved design changes to polycarbonate syringes.
SourceFDA advises patients to switch from True Metrix glucometers due to links with serious injuries and one death.
SourceThe FDA has released draft guidance on best practices for responding to Form 483 after inspections.
SourceAI integration in medical devices requires understanding regulatory status and managing training data as a device component.
SourceValidation strategies for medical devices must adapt as production scales up to ensure compliance and process stability.
SourceUnion Community Care in Pennsylvania partners with Medline for medical-surgical product supply and support services.
SourceAbbott's neurostimulation systems include a Surgery Mode to protect devices from electrosurgical interference.
SourceFDA advises users of Trividia glucometer to switch to alternative blood glucose meters due to error code issues.
SourceThe review highlights the supply chain resilience challenges in the pharma and medical devices sectors.
SourceDeviceTalks Boston 2026 will feature keynotes and panels from medical device OEMs on May 27-28.
SourceECRI urges Congress to enhance regulatory transparency for digital health tools, citing risks of unvalidated devices.
SourceAxoft secured $55m to enhance its implantable brain-computer interface and advance US regulatory efforts.
SourceMedFlux monitors regulators and medical device market sources across priority countries so regulatory, quality, and strategy teams can review changes without manually checking agency databases.